A recent cross-sectional study found that there was no correlation between the use of oral hypoglycemic agents, insulin and Asprosin in T2DM patients after multiple linear regression analysis [21], which is consistent with the results of this study. The gene discussed is INS; the disease is type 2 diabetes mellitus.